condition	mean	min	max
0.1 mm CuSO4,WT	0.0	0.0	0.0
1-napp-1,WT	4.18513	0.0	8.37026
1n,MATa,NaCl,WT	0.0	0.0	0.0
1n,MATa,WT	0.0	0.0	0.0
1n,MATa,unstressed,WT	0.0	0.0	0.0
1n,MATalpha,WT	0.0	0.0	0.0
1n,WT	0.0	0.0	0.0
1n,addition of 1nm-pp1,WT	2.17237	0.0	4.34474
200 mm hu,WT	0.0	0.0	0.0
39C,YPD,WT	0.0	0.0	0.0
SC-URA + 20g/l glucose,WT	0.0	0.0	0.0
SDC,WT	0.0	0.0	0.0
WT	0.8224709019607843	0.0	170.875
YEP + lactic acid + 2% gal,WT	0.0	0.0	0.0
YEP + lactic acid,WT	0.0	0.0	0.0
YP + 3% glycerol,WT	0.0	0.0	0.0
YPD,WT	1.299675	0.0	20.7948
YPDA,WT	0.0	0.0	0.0
YPEG,WT	0.0	0.0	0.0
azetidine,YPD,WT	0.0	0.0	0.0
cmk treatment,WT	4.255725	0.0	17.0229
dmso,WT	10.0062	0.0	20.0124
elutriation + 1nm-pp1,WT	0.0	0.0	0.0
fluco,YPD,WT	0.0	0.0	0.0
gal, 2h + hu 200 mm,WT	0.0	0.0	0.0
gal, 4h + hu 200 mm,WT	0.0	0.0	0.0
gal,WT	0.0	0.0	0.0
glucose,WT	0.0	0.0	0.0
heatshock,WT	0.9089433333333333	0.0	5.45366
hu, 1h,WT	0.0	0.0	0.0
hu, 2h,WT	0.0	0.0	0.0
hu, 4h,WT	0.0	0.0	0.0
log,WT	0.0	0.0	0.0
med 35 6aa,WT	0.0	0.0	0.0
med 35 ammonium,WT	0.0	0.0	0.0
med 35 complete,WT	0.0	0.0	0.0
menadione,YPD,WT	0.0	0.0	0.0
mid-log,WT	0.0	0.0	0.0
mid-log,untreated,WT	0.0	0.0	0.0
mid-log,vts1 OE,WT	0.0	0.0	0.0
min med, chemostat,WT	0.0	0.0	0.0
rap,YPD,WT	0.0	0.0	0.0
ribo depletion,WT	0.0	0.0	0.0
salt,YPD,WT	0.0	0.0	0.0
stat,WT	0.0	0.0	0.0
syn dext,WT	7.726325	0.0	30.9053
synthetic complete med,20C,WT	0.0	0.0	0.0
synthetic defined med,WT	0.0	0.0	0.0
treated,WT	0.0	0.0	0.0
tunicamycin,YPD,WT	0.0	0.0	0.0
untreated,WT	0.0	0.0	0.0
ypsorbitol (2.02%),YPD,WT	0.0	0.0	0.0